S
Shenzhen Neptunus Interlong Bio-Technique
Focusing on pharmaceutical and healthfood R&D, Manufacturing, Wholesale and Retail, Export & Import
About Shenzhen Neptunus Interlong Bio-Technique
Interlong is a biotechnology company focused on improving health and quality of life through innovative medical solutions. Operating primarily in China, Interlong serves a diverse range of clients including healthcare providers, pharmaceutical companies, and research institutions. The company leverages advanced biotechnology to develop high-quality products and services aimed at disease prevention and treatment. Interlong's business model revolves around research and development, manufacturing, and distribution of medical products, generating revenue through product sales and service contracts. The company benefits from China's growing emphasis on healthcare, driven by economic development and an aging population, which has led to increased domestic demand for medical solutions. Interlong's commitment to health is reflected in its mission to contribute to human health and improve people's lives through continuous innovation and high-quality offerings.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Nov 2022 | $14M | $55M | CICC Fund · Qiandao Fund | ↗ |
| IPOExit | Dec 1998 | $0 | — | Undisclosed | — |
Growth signals
Shenzhen Neptunus Interlong Bio-Technique's team grew 2.6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Shenzhen Neptunus Interlong Bio-Technique in the Shenzhen ecosystem
The Shenzhen Neptunus Interlong Bio-Technique office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
- CFCICC Fund
- QFQiandao Fund
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Shenzhen Neptunus Interlong Bio-Technique on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Shenzhen Neptunus Interlong Bio-Technique’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








